Insperity (NSP) Competitors $56.92 -0.68 (-1.18%) Closing price 03:59 PM EasternExtended Trading$55.68 -1.24 (-2.17%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NSP vs. CCRN, RHI, KFY, ASGN, MAN, BBSI, HSII, KFRC, KELYA, and TBIShould you be buying Insperity stock or one of its competitors? The main competitors of Insperity include Cross Country Healthcare (CCRN), Robert Half (RHI), Korn/Ferry International (KFY), ASGN (ASGN), ManpowerGroup (MAN), Barrett Business Services (BBSI), Heidrick & Struggles International (HSII), Kforce (KFRC), Kelly Services (KELYA), and TrueBlue (TBI). Insperity vs. Its Competitors Cross Country Healthcare Robert Half Korn/Ferry International ASGN ManpowerGroup Barrett Business Services Heidrick & Struggles International Kforce Kelly Services TrueBlue Insperity (NYSE:NSP) and Cross Country Healthcare (NASDAQ:CCRN) are both business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings. Do institutionals and insiders have more ownership in NSP or CCRN? 93.4% of Insperity shares are held by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are held by institutional investors. 5.3% of Insperity shares are held by company insiders. Comparatively, 4.9% of Cross Country Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media refer more to NSP or CCRN? In the previous week, Insperity had 1 more articles in the media than Cross Country Healthcare. MarketBeat recorded 2 mentions for Insperity and 1 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.63 beat Insperity's score of 0.14 indicating that Cross Country Healthcare is being referred to more favorably in the news media. Company Overall Sentiment Insperity Neutral Cross Country Healthcare Positive Which has higher valuation and earnings, NSP or CCRN? Insperity has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Insperity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInsperity$6.58B0.33$91M$1.6833.88Cross Country Healthcare$1.34B0.29-$14.56M-$0.53-22.66 Which has more risk & volatility, NSP or CCRN? Insperity has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.36, suggesting that its share price is 64% less volatile than the S&P 500. Do analysts rate NSP or CCRN? Insperity presently has a consensus target price of $80.00, indicating a potential upside of 40.54%. Cross Country Healthcare has a consensus target price of $17.93, indicating a potential upside of 49.29%. Given Cross Country Healthcare's stronger consensus rating and higher probable upside, analysts clearly believe Cross Country Healthcare is more favorable than Insperity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Insperity 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67Cross Country Healthcare 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is NSP or CCRN more profitable? Insperity has a net margin of 0.95% compared to Cross Country Healthcare's net margin of -1.41%. Insperity's return on equity of 52.17% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Insperity0.95% 52.17% 2.87% Cross Country Healthcare -1.41%2.56%1.84% SummaryInsperity beats Cross Country Healthcare on 11 of the 15 factors compared between the two stocks. Get Insperity News Delivered to You Automatically Sign up to receive the latest news and ratings for NSP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NSP vs. The Competition Export to ExcelMetricInsperityStaffing IndustryBusiness SectorNYSE ExchangeMarket Cap$2.17B$1.55B$15.09B$20.64BDividend Yield4.17%3.27%2.76%3.68%P/E Ratio33.8828.0728.1727.27Price / Sales0.334.7444.4655.18Price / Cash15.958.5326.2421.88Price / Book21.983.836.444.60Net Income$91M$43.21M$196.70M$995.22M7 Day Performance-5.88%-1.03%0.50%-0.80%1 Month Performance-5.58%3.55%5.42%3.55%1 Year Performance-43.10%-21.42%21.87%7.35% Insperity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NSPInsperity4.5098 of 5 stars$56.92-1.2%$80.00+40.5%-40.0%$2.17B$6.58B33.884,500CCRNCross Country Healthcare3.8348 of 5 stars$12.75-2.0%$17.93+40.6%-14.3%$426.51M$1.34B-24.068,205RHIRobert Half4.9409 of 5 stars$41.19-3.9%$48.71+18.3%-37.3%$4.38B$5.80B20.6014,700Positive NewsUpcoming EarningsKFYKorn/Ferry International4.0853 of 5 stars$73.34-0.9%$81.00+10.4%+5.6%$3.82B$2.76B15.879,253ASGNASGN3.6093 of 5 stars$49.52-6.3%$63.67+28.6%-51.8%$2.32B$4.10B10.593,200News CoverageUpcoming EarningsGap DownHigh Trading VolumeMANManpowerGroup4.5515 of 5 stars$42.99-2.9%$50.60+17.7%-39.7%$2.05B$17.85B18.6926,700Upcoming EarningsAnalyst ForecastBBSIBarrett Business Services4.2855 of 5 stars$42.51-1.5%$45.00+5.9%+27.5%$1.11B$1.14B21.803,658HSIIHeidrick & Struggles International2.1344 of 5 stars$48.12-0.8%$49.00+1.8%+42.3%$1.00B$1.12B137.492,201KFRCKforce4.4514 of 5 stars$42.23-3.5%$53.67+27.1%-35.1%$786.75M$1.38B15.7612,000Positive NewsKELYAKelly Services4.5144 of 5 stars$12.49+0.8%$25.00+100.2%-43.4%$432.26M$4.33B-20.824,200Positive NewsTBITrueBlue3.6733 of 5 stars$6.74+1.4%$10.00+48.4%-39.6%$198.60M$1.57B-1.474,200 Related Companies and Tools Related Companies CCRN Competitors RHI Competitors KFY Competitors ASGN Competitors MAN Competitors BBSI Competitors HSII Competitors KFRC Competitors KELYA Competitors TBI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NSP) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insperity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Insperity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
